相关实验视频
Updated: Jul 6, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
通过EMT和PI3K/AKT通路,IRS1促进甲状腺癌的转移
Fang Yu1, Dongdong Huang1, Yeye Kuang2
1Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Clinical endocrinology
|January 3, 2024
概括
胰岛素受体基质1 (IRS1) 蛋白质促进甲状腺癌转移和攻击性. 高IRS1表达与晚期和远程传播有关,这表明它是潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 信号传输 信号传输
背景情况:
- 胰岛素受体基质1 (IRS1) 是胰岛素类生长因子信号传递中的关键适应蛋白.
- 在各种固体瘤中确立了IRS1在瘤发生和转移中的参与.
研究的目的:
- 研究IRS1在甲状腺癌进展和转移中的作用.
- 评估IRS1作为潜在的诊断标记物和甲状腺癌治疗点.
主要方法:
- 在131种转移性甲状腺癌组织中对IRS1表达的免疫组织化学分析.
- 在体外功能测试包括伤口愈合,细胞入侵和殖民地形成.
- RNA测序 (RNA-seq) 和西班牙血迹,以阐明IRS1的调控机制.
主要成果:
- 在甲状腺癌中,IRS1的表达很高,与远程转移和晚期临床阶段正相关.
- 在实验室中,IRS1显著调解了甲状腺癌细胞的迁移,入侵和殖民地形成.
- 通过RNA-seq检测发现,IRS1通过表皮细胞-介质细胞过渡和PI3K/AKT通路促进甲状腺癌转移.
结论:
- 过度表达IRS1有助于甲状腺癌的攻击性.
- IRS1 作为风险分层的潜在生物标志物.
- 在甲状腺癌治疗中,IRS1 是一个有前途的治疗点.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Electron Transport Chain: Complex I and II
13.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.5K

